HANNAH ATKINS: Open Payments
NPI 1154659043 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 9 payments from 6 companies in 2025. Trend: 2023 $487 · 2024 $206 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $151 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| GlaxoSmithKline, LLC. | 1 | $121 |
| Gilead Sciences, Inc. | 3 | $55 |
| Abbott Laboratories | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
Products named: Prolastin-C Liquid, FARXIGA, AREXVY, JOT DX, KISUNLA, AIRSUPRA.
Industry payments across KY — which companies pay providers there.
